01 Woluwe-Saint-Lambertexpand_more
Oncology and Hematologic Malignancies
In Woluwe-Saint-Lambert, a large share of clinical research focuses on cancer and related blood disorders, with studies spanning solid tumors and hematologic malignancies. The main goal is to test new treatment options, improve disease control, and extend survival for patients with advanced or hard-to-treat disease.
Breast cancer, lung cancer, colorectal cancer, and prostate cancer
Leukemias, lymphomas, multiple myeloma, and myelodysplastic syndromes
Melanoma, ovarian cancer, bladder cancer, and head and neck cancers
Evaluating targeted therapies, immunotherapy, and improved treatment combinations
Research at the city’s sites also includes biomarker-driven studies, aiming to match therapies more closely to tumor characteristics and resistance patterns.
Gastroenterology and Liver Diseases
Another major area covers digestive system diseases and liver disorders, including chronic inflammatory conditions and metabolic liver disease. These trials are designed to reduce symptoms, control inflammation, and assess whether newer therapies can improve long-term outcomes.
Crohn’s disease, ulcerative colitis, and inflammatory bowel disease
Primary biliary cholangitis, primary sclerosing cholangitis, and cholestatic pruritus
Non-alcoholic steatohepatitis, metabolic dysfunction-associated steatotic liver disease, and cirrhosis
Testing better symptom relief, disease control, and safety of emerging treatments
Several studies also explore conditions such as pancreatic, gastric, and biliary cancers linked to the gastrointestinal tract.
Immunology, Autoimmune, and Inflammatory Disorders
Clinical trials in immune system diseases and autoimmune disorders are prominent, reflecting broad interest in chronic inflammatory illnesses. The research aims to improve symptom management, reduce flares, and support longer-term disease control.
Rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis
Lupus, myasthenia gravis, and multiple sclerosis
Atopic dermatitis, psoriasis, urticaria, and vitiligo
Studying targeted immune-modulating therapies and treatment durability
This area also includes rare immune-mediated conditions, giving patients access to research beyond standard care.
Respiratory and Pulmonary Research
A substantial part of the research portfolio centers on respiratory tract diseases and chronic lung conditions. These trials seek better ways to ease breathing problems, slow disease progression, and improve quality of life.
Asthma, chronic obstructive pulmonary disease, and bronchiectasis
Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
Chronic rhinosinusitis, pneumonia, and refractory chronic cough
Evaluating new anti-inflammatory and disease-modifying approaches
Some studies also address severe respiratory infections and complex lung disease, highlighting the breadth of pulmonary research in the city.
Cardiovascular and Metabolic Conditions
Trials in cardiovascular diseases and metabolic disorders are aimed at lowering risk, protecting organ function, and preventing complications. The focus includes both common chronic illnesses and high-risk conditions with major long-term health impact.
Heart failure, coronary artery disease, and atherosclerotic cardiovascular disease
Hypertension, elevated lipoprotein(a), and symptomatic hypertrophic cardiomyopathy
Obesity, type 1 diabetes, and metabolic liver disease
Testing therapies that may improve cardiovascular outcomes and metabolic control
Research in this field often combines prevention-focused studies with treatment studies for patients already living with advanced disease.
Kidney and Urologic Diseases
Research on kidney diseases and urologic disorders forms another important part of the clinical landscape. Studies are examining ways to preserve kidney function, reduce proteinuria, and manage hereditary or progressive renal conditions.
Chronic kidney disease, proteinuric kidney disease, and kidney failure
Autosomal dominant polycystic kidney disease and Alport syndrome
Urothelial carcinoma, bladder cancer, and prostate cancer
Evaluating renal protection, symptom control, and new cancer therapies
The work includes both adult and pediatric studies, reflecting interest in kidney health across the lifespan.
Neurology and Cognitive Disorders
Nervous system diseases are well represented, with trials addressing both chronic neurologic disorders and conditions that affect cognition and movement. The overall aim is to slow progression, improve function, and support daily independence.
Multiple sclerosis, epilepsy, and narcolepsy
Alzheimer’s disease, mild cognitive impairment, and early cognitive decline
Myasthenia gravis, cerebral palsy, and rare neurodevelopmental disorders
Testing therapies that may modify disease activity or improve symptoms
This area includes both common neurological conditions and rare diseases, adding depth to the city’s research profile.
Dermatology and Skin Disorders
Clinical trials in skin and connective tissue diseases are exploring chronic inflammatory and autoimmune skin conditions, as well as hair and pigmentation disorders. The goal is to improve symptom relief, skin appearance, and long-term disease control.
Atopic dermatitis, psoriasis, and hidradenitis suppurativa
Vitiligo, alopecia areata, and prurigo nodularis
Lupus-related skin disease and chronic cutaneous lupus erythematosus
Assessing newer targeted treatments for persistent dermatologic disease
These studies often focus on conditions that can strongly affect comfort, self-image, and quality of life.
Pediatrics, Rare Diseases, and Genetic Conditions
A notable portion of the research portfolio addresses congenital, hereditary, and neonatal diseases, with an emphasis on children and rare disorders. These trials aim to fill treatment gaps where options are limited or still evolving.
Congenital adrenal hyperplasia, growth disorders, and prematurity-related conditions
Rare genetic kidney, liver, and metabolic diseases
Neurodevelopmental disorders such as Rett syndrome and CDKL5 deficiency disorder
Evaluating therapies for rare, inherited, or early-onset diseases
The presence of pediatric and orphan-disease research adds an important specialist dimension to the city’s clinical trial activity.
Infectious Diseases and Public Health
Trials in bacterial infections and mycoses, virus diseases, and broader public health topics address both treatment and prevention. Research is focused on limiting complications, improving recovery, and strengthening care for vulnerable patients.
HIV infection, hepatitis B, cytomegalovirus, and varicella
Pneumonia, sepsis, candidemia, and invasive fungal infections
Monkeypox and other emerging infectious threats
Testing prevention strategies and better infection management approaches
Some studies also support transplant and immunocompromised patients, where infection risk is especially high.
Hematology, Coagulation, and Immune Blood Disorders
The city also hosts trials in hemic and lymphatic diseases, including bleeding disorders and other blood-related conditions. These studies are designed to improve safety, reduce complications, and offer more effective long-term management.
Hemophilia A, hemophilia B, and paroxysmal nocturnal hemoglobinuria
Anemia associated with chronic kidney disease and coagulopathy
Thrombotic microangiopathy and hemolytic uremic syndrome
Evaluating replacement, supportive, and disease-modifying therapies
This research area often overlaps with kidney disease, transplantation, and rare inherited disorders.
Psychiatry, Behavior, and Sleep Disorders
A smaller but important set of studies addresses mental disorders, behavior, and sleep-related problems. These trials look for ways to improve daily functioning, mood, and overall well-being.
Major depressive disorder, cognitive symptoms, and anhedonia
Narcolepsy and sleep disturbances linked to hormonal changes
Behavioral and psychological aspects of chronic illness
Exploring supportive treatments that may improve quality of life
This adds breadth to the trial landscape by addressing symptoms that affect both physical and emotional health.
Back to Belgium
